Akso Health Group Sponsored ADR AHG
0.75
(0.01)
(1.32%)
as of 25 Sep
- Market cap
- $649.1M
- P/E
- 0.0×
Follow AHG
| Older periods | Mar '23 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(139.96%) | (99.22%) | 0.00% | 0.00% | |
| (69.78%) | (49.98%) | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | (231.55%) | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 105.61 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.52) | (0.54) | 0.00 | 0.00 | |
Free Cash Flow |
(11.88) | (12.44) | (9.50) | (182.54) | |
Capital Expenditures |
— | — | (1.59) | (177.19) | |
Piotroski F-Score |
— | 2.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(71.34%) | (83.50%) | (2.67%) | (2.55%) | |
Accounts Receivable Turnover |
0.00 | 1.57 | 0.00 | 0.00 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Operating CF/Net income |
0.65 | 1.01 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
— | — | 5.41 | 107.92 | |
Capex/Depreciation |
— | — | (2.59) | (106.62) | |
Revenue per Share |
0.85 | 0.88 | — | — | |
Operating CF per Share |
(0.52) | (0.54) | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(93.34%) | (61.29%) | — | — |
Columns are period end dates